Matches in Nanopublications for { ?s ?p "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP49893.RArh_Ns61fAi6bxhwJAAkpPRMm8vKcuDrwoKrg6LOR1kA130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49893.RArh_Ns61fAi6bxhwJAAkpPRMm8vKcuDrwoKrg6LOR1kA130_provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP67233.RAkWH7Rzx1tPY2CdwMQyhPY80uyiM87A-v9w-vVXPmOoY130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67233.RAkWH7Rzx1tPY2CdwMQyhPY80uyiM87A-v9w-vVXPmOoY130_provenance.
- NP67235.RAu3ETOM__M2k7NZO9P71NRQ3JS8B9Y4zCl6vdoRfURfk130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67235.RAu3ETOM__M2k7NZO9P71NRQ3JS8B9Y4zCl6vdoRfURfk130_provenance.
- NP67234.RAKUJ508bQscM7rACW4Iq2nbtcTdqH-pherjj3BxAwUq8130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67234.RAKUJ508bQscM7rACW4Iq2nbtcTdqH-pherjj3BxAwUq8130_provenance.
- NP67237.RAKyrJv8AaEgm3Fy5feiBK3U8RugfcAg70qU0oTrfB8OY130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67237.RAKyrJv8AaEgm3Fy5feiBK3U8RugfcAg70qU0oTrfB8OY130_provenance.
- NP67236.RA77FQgiMJaSN3LKQ5c05J2pK6AjXrBajCtYfn6e26yqo130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67236.RA77FQgiMJaSN3LKQ5c05J2pK6AjXrBajCtYfn6e26yqo130_provenance.
- NP67238.RA2kZMJgaSm1hOEkS_qrC6Vd5qBQNZxjQz1SaHQf-0M04130_assertion description "[Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67238.RA2kZMJgaSm1hOEkS_qrC6Vd5qBQNZxjQz1SaHQf-0M04130_provenance.